High prevalence of cervical intra-epithelial neoplasia in women treated for pelvic inflammatory disease

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 81, Issue 1, 1998, Pages 51-54

  Giraud, J ^a   Coiffic, J ^a   Poulain, P ^a   Kerisit, J ^b  

^a Hotel Dieu CHU Rennes   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Cervical intra epithelial neoplasia; Pelvic inflammatory disease; Sexually transmitted diseases

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0032189071     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00146-8     Document Type: Article

References (24)

1. [1] Cox JT. Epidemiology of cervical intra epithelial neoplasia: the role of human papillomavirus. Clin Obstet Gynecol 1995;9:1-37.
2. [2] Crum CP, Nuovo GJ. Epidemiology, pathogenesis, and natural history of papillomavirus-related neoplasia. In: Genital papillomavirus and related neoplasms. New York: Raven Press, 1991:64-87.
3. [3] Grodstein F, Tothman KJ. Epidemiology of pelvic inflammatory disease. Epidemiology 1994;5:234-42.
4. [4] Autillo-Touati A, Benmoura D, Palazzi O, et al. Quatre années de dépistage sur frottis cervical des lésions du col utérin. J Gynecol Obstet Biol Reprod 1992;21:754-60.
5. [5] Briggs RM, Holmes KK, Kiviat N, et al. High prevalence of cervical dysplasia in STD clinic patients warrants routine cytologic screening. AJPH 1980;70:1212-4.
6. [6] Boulanger JC, Gondry J. Lésions précancéreuses du col utérin. In: Tournaire M, editor. Mises à jour en gynécologie-obstétrique. Paris: Vigot, 1993:153-202.
7. [7] Holst N, Abyholm T. Precancerous lesions of the cervix uteri in infertile women. Br Med J 1983;287:1019-20.
8. [8] Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern hispanic and non-hispanic white women. J Am Med Assoc 1994;271:1181-8.
9. [9] Kamb ML. Cervical cancer screening of women attending sexually transmitted disease clinics. Clin Infect Dis 1995;20(Suppl 1):S98-103.
10. [10] Washington AK, Aral SO, Wolner-Hanssen P, et al. Assessing risk of pelvic inflammatory disease and its sequelae. J Am Med Assoc 1991;13:2581-6.
11. [11] Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol 1990;162:639-44.
12. [12] Bornstein J, Rahat MA, Abramovici H. Etiology of cervical cancer: current concepts. Obstet Gynecol Surv 1995;50:146-54.
13. [13] Brinton LA. Epidemiology of cervical cancer - overview. In: Munoz N, Bosch FX, Shah KV, Meheus A, editors. The epidemiology of cervical cancer and human papillomavirus. Lyon: IARC, 1992:3-23.
14. [14] Duggan MA. Human papillomaviruses in gynecological cancer. Curr Opin Obstet Gynecol 1996;8:56-62.
15. [15] Guijon FB, Paraskevas M, Brunham R. The association of sexually transmitted diseases with cervicalintraepithelialneoplasia. Am J Obstet Gynecol 1985;151:185-90.
16. [16] La Vecchia C, Franceschi S, Decarli A, et al. Sexual factors, veneral diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986;58:935-41.
17. [17] Parazzini F, La Vecchia C, Negri E, et al. Risk factors for cervical intraepithelial neoplasia. Cancer 1992;69:2276-82.
18. [18] Stone KM, Zaidi A, Rosero-Bixby L, et al. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 1995;6:409-14.
19. [19] de Vet HCW, Knipschild PG, Sturmans F. The role of sexual factors in the aetiology of cervical dysplasia. Int J Epidemiol 1993;22:798-803.
20. [20] Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:997-1003.
21. [21] Schneider A. Risk factors for the detection of genital HPV infection. In: Monsonego J, editor. Papillomavirus in human pathology. Rome: Ares-Serono Symposia Publications, 1995:165-171.
22. [22] Syrjanen K. Exposure time and other risk factors of HPV: biologic and exposure aspects. In: Monsonego J, editor. Papillomavirus in human pathology. Rome: Ares-Serono Symposia Publications, 1995:75-86.
23. [23] Bosch FX. Epidemiology of cervical cancer and of HPV infections, Part 1. In: Munoz N, Bosch FX, Shah KV, Meheus A, editors. The epidemiology of cervical cancer and human papillomavirus. Lyon: IARC, 1992:53-56.
24. [24] Brisson J, Roy M, Fortier M, et al. Condyloma and intraepithelial neoplasia of the uterine cervix: a case-control study. Am J Epidemiol 1988;128:337-42.